Leerink Partners Begins Coverage on Medpace (NASDAQ:MEDP)
Leerink Partners initiated coverage on shares of Medpace (NASDAQ:MEDP – Free Report) in a research note released on Monday morning, Marketbeat.com reports. The brokerage issued a market perform rating and a $330.00 target price on the stock. Separately, Robert W. Baird upped their target price on shares of Medpace from $354.00 to $362.00 and gave […]
